ERRATUM: In Vitro Evaluation of Antiglycation, Antioxidation, and -Glucosidase Inhibitory Activities of Ethanolic Extracts of Terminalia Bellirica and Terminalia Chebula Fruits
DOI:
https://doi.org/10.26538/tjnpr/v9i10.72Keywords:
a-glucosidase, antioxidation, antiglycation, Phytochemicals, Terminalia chebula, Terminalia belliricaAbstract
Accumulation of advanced glycation end-products (AGEs) due to hyperglycemia and oxidative stress contributes to diabetic complications. Terminalia bellirica and Terminalia chebula are traditional medicinal fruits rich in bioactive phytochemicals with various pharmacological effects. This study assesses their hydroethanolic extracts (TBE and TCE) for phytochemical content, antiglycation, antioxidation, and α-glucosidase inhibitory activities, highlighting their potential for diabetes management. Total phenolics and tannins were measured by the Folin-Ciocalteu method, and flavonoids by aluminum chloride assay. Antiglycation activities were assessed with a bovine serum albumin/fructose model. Superoxide (SO) anion radical inhibition was measured through a riboflavin-light-nitroblue tetrazolium assay, while metal chelation activity was determined using an iron-ferrozine assay. Alpha-glucosidase inhibition was assessed with p-nitrophenyl-α-D-glucopyranoside (p-NPG) substrate. TBE showed significantly higher phenolics (516.44 ± 2.08 mg GAE/g) and tannins (591.0 ± 8.43 mg TAE/g) than TCE, indicating its superior phytochemical content (p < 0.01). Regarding antiglycation activity, TBE showed significantly lower IC50 for dicarbonyl (2.03 ± 0.21 μg/mL) and AGEs (16.56 ± 4.44 μg/mL) than TCE (4.15 ± 0.20 μg/mL and 37.71 ± 1.14 μg/mL), indicating stronger antiglycation activity (p < 0.05). Moreover, TBE demonstrated greater effectiveness in both SO scavenging and ferric ion chelation assays (p < 0.05). In the α-glucosidase inhibition assay, both extracts exhibited superior efficacy compared to the standard acarbose (p < 0.01). These findings suggest that TBE possesses strong antiglycation, antioxidation, and α-glucosidase inhibitory activities, indicating its potential as a natural agent for managing oxidative stress-related diabetic complications. Further research is warranted to explore its mechanisms and therapeutic applications. (249 words).
References
1. Thapsuwan S, Phulkerd S, Chamratrithirong A, Gray RS, Jindarattanaporn N, Loyfah N, Thongcharoenchupong N, Pattaravanich U. Relationship between consumption of high fat, sugar or sodium (HFSS) food and obesity and non-communicable diseases. BMJ Nutr Prev Health. 2024; 7(1): 78-87.
2. Biswas T, Townsend N, Huda MM, Maravilla J, Begum T, Pervin S, Ghosh A, Mahumud RA, Islam S, Anwar N, Rifhat R, Munir K, Gupta RD, Renzaho AMN, Khusun H, Wiradnyani LAA, Radel T, Baxter J, Rawal LB, McIntyre D, Mamun A. (2022). Prevalence of multiple non-communicable diseases risk factors among adolescents in 140 countries: A population-based study. EClinicalMedicine. 2022; 52: 101591.
3. Phuwajaroanpong A, Chaniad P, Plirat W, Phoopha S, Septama AW, Chukaew A, Punsawad C. Antiplasmodial properties of aqueous and ethanolic extracts of ten herbal traditional recipes used in Thailand against Plasmodium falciparum. Trop Med Infect Dis. 2022; 7(12): 417.
4. Gupta A, Kumar R, Bhattacharyya P, Bishayee A, Pandey AK. Terminalia bellirica (Gaertn.) roxb. (Bahera) in health and disease: A systematic and comprehensive review. Phytomedicine. 2020; 77: 153278.
5. Bulbul MRH, Chowdhury MNU, Naima TA, Sami SA, Imtiaj MS, Hunda N, Uddin MG. A comprehensive review on the diverse pharmacological perspectives of Terminalia chebula Retz. Heliyon. 2022; 8(8): e10220.
6. Das G, Kim DY, Fan C, Gutiérrez-Grijalva EP, Heredia JB, Nissapatorn V, Mitsuwan W, Pereira M. L, Nawaz M, Siyadatpanah A, Norouzi R, Sawicka B, Shin HS, Patra JK. Plants of the genus Terminalia: An insight on its biological potentials, pre-clinical and clinical studies. Front Pharmacol. 2020; 11: 561248.
7. Nawaz M, Afridi MN, Ullah I, Khan IA, Ishaq MS, Su Y, Rizwan HM, Cheng KW, Zhou Q, Wang M. The inhibitory effects of endophytic metabolites on glycated proteins under non-communicable disease conditions: A review. Int J Biol Macromol. 2024; 269: 131869.
8. Bangar NS, Gvalani A, Ahmad S, Khan MS, Tupe RS. Understanding the role of glycation in the pathology of various non-communicable diseases along with novel therapeutic strategies. Glycobiology. 2022; 32(12): 1068-1088.
9. Bhatti JS, Sehrawat A, Mishra J, Sidhu IS, Navik U, Khullar N, Kumar S, Bhatti GK, Reddy PH. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. Free Radic Biol Med. 2022; 184: 114-134.
10. Caturano A, D’Angelo M, Mormone A, Russo V, Mollica MP, Salvatore T, Galiero R, Rinaldi L, Vetrano E, Marfella R, Monda M, Giordano A, Sasso FC. Oxidative stress in type 2 diabetes: Impacts from pathogenesis to lifestyle modifications. Curr Issues Mol Biol. 2023; 45(8): 6651-6666.
11. Singh A, Bajpai V, Kumar S, Kumar B, Srivastava M, Rameshkumar KB. Comparative profiling of phenolic compounds from different plant parts of six Terminalia species by liquid chromatography–tandem mass spectrometry with chemometric analysis. Ind Crops Prod. 2016; 87: 236-246.
12. Aryal S, Baniya MK, Danekhu K, Kunwar P, Gurung R, Koirala N. Total phenolic content, flavonoid content and antioxidant potential of wild vegetables from Western Nepal. Plants (Basel). 2019; 8(4): 96.
13. Jirasripongpun K, Jirakanjanakit N, Pola S, Obsuwan K. Antioxidation and anti-melanogenesis of three colored flowers of Dendrobium hybrids. Sci Eng Health Stud. 2022; 16: 22030006.
14. Wacharatewinkul Y, Riangmoo A. Physicochemical and antimicrobial activity of Thao Yai Mom (Tacca leontopetaloides (L.) Kuntze.) Extracts. SWU J Sci Technol. 2021; 12: 23-35.
15. Zuo G-L, Kim HY, Guillen Quispe YN, Wang Z-Q, Hwang SH, Shin K-O, Lim SS. Efficient separation of phytochemicals from Muehlenbeckia volcanica (Benth.) Endl. by polarity-stepwise elution counter-current chromatography and their antioxidant, antiglycation, and aldose reductase inhibition potentials. Molecules. 2021; 26(1): 224.
16. Xu X, Djohari KN, Jiang Y, Zhou W. Deciphering the inhibitory mechanisms of betanin and phyllocactin from Hylocereus polyrhizus peel on protein glycation, with insights into their application in bread. Food Chem. 2024; 452: 139594.
17. Nadee P, Jaruchotikamol A, Cushnie B. Antioxidant capacity and phytochemical analysis of the traditional Thai remedy Benchalokawichian. Trop J Nat Prod Res. 2024; 8(8): 8054-8060.
18. Gulcin İ, Alwasel SH. Metal ions, metal chelators and metal chelating assay as antioxidant method. Processes. 2022; 10(1): 132.
19. Amin S, Ullah B, Ali M, Rauf A, Khan H, Uriarte E, Sobarzo-Sánchez E. Potent in vitro α-glucosidase inhibition of secondary metabolites derived from Dryopteris cycadina. Molecules. 2019; 24(3): 427.
20. Sheng Z, Zhao J, Muhammad I, Zhang Y. Optimization of total phenolic content from Terminalia chebula Retz. fruits using response surface methodology and evaluation of their antioxidant activities. PLos One. 2018; 13(8): e0202368.
21. Sabuhom P, Subin P, Luecha P, Nualkaew S, Nualkaew N. Effects of plant part substitution in a Thai traditional recipe on α-glucosidase inhibition. Trop J Nat Prod Res. 2023; 7(5): 2919-2925.
22. Chekdaengphanao P, Jaiseri D, Sriraj P, Aukkanimart R, Prathumtet J, Udonsan P, Boonmars T. Anticancer activity of Terminalia chebula, Terminalia bellirica, and Phyllanthus emblica extracts on cholangiocarcinoma cell proliferation and induction of apoptosis. J Herb Med. 2022; 35: 100582.
23. Moe TS, Win HH, Hlaing TT, Lwin WW, Htet ZM, Mya KM. Evaluation of in vitro antioxidant, antiglycation and antimicrobial potential of indigenous Myanmar medicinal plants. J Integr Med. 2018; 16(5): 358-366.
24. Uddin N, Muhammad N, Nisar M, Aisha, Ali N, Ullah R, Ali EA, Khan AA, Rahman IU, Khan A, Zeb A. Distribution of
polyphenolic compounds, antioxidant potential, and free amino acids in Ziziphus fruits extract; a study for determining the influence of wider geography. Food Sci Nutr. 2022; 10(5): 1414-1430.
25. Gupta A, Kumar R, Pandey AK. Antioxidant and antidiabetic activities of Terminalia bellirica fruit in alloxan induced diabetic rats. S Afr J Bot. 2020; 130: 308-315.
26. Chaves JO, De Souza MC, Da Silva LC, Lachos-Perez D, Torres-Mayanga PC, Machado APDF, Forster-Carneiro T, Vázquez-Espinosa M, González-de-Peredo AV, Barbero GF, Rostagno MA. Extraction of flavonoids from natural sources using modern techniques. Front Chem. 2020; 8: 507887.
27. Jing W, Xiaolan C, Yu C, Feng Q, Haifeng Y. Pharmacological effects and mechanisms of tannic acid. Biomed Pharmacother. 2022; 154: 113561.
28. Atta A, Shahid M, Kanwal Z, Jafri SA, Riaz M, Xiao H, Abbas M, Egbuna C, Simal-Gandara J. Inhibition of oxidative stress and advanced glycation end product formation in purified BSA/glucose glycation system by polyphenol extracts of selected nuts from Pakistan. Food Sci Nutr. 2023; 11(6): 3414-3421.
29. Gugliucci A. Formation of fructose-mediated advanced glycation end products and their roles in metabolic and inflammatory diseases. Adv Nutr. 2017; 8(1): 54-62.
30. Khan M, Liu H, Wang J, Sun B. Inhibitory effect of phenolic compounds and plant extracts on the formation of advance glycation end products: A comprehensive review. Food Res Int. 2020; 130: 108933.
31. Yousof Ali M, Jannat S, Mizanur Rahman M. Ginsenoside derivatives inhibit advanced glycation end product formation and glucose–fructose mediated protein glycation in vitro via a specific structure–activity relationship. Bioorg Chem. 2021; 111: 104844.
32. Erim B, Binici Hİ. Advanced glycation end products: understanding their health risks and effective prevention strategies. Nutrire. 2024; 49(2): 54.
33. Mustafa YF. Harmful free radicals in aging: A narrative review of their detrimental effects on health. Ind J Clin Biochem. 2024; 39(2): 154-167.
34. Chatterjee J, Hoda MU, Das S. In vitro screening of Triphala, its compositions and identification of a few phenolic compounds to determine their antioxidant, anti-malarial and hepatoprotective properties: a GC/MS-assisted metabolomics study. Chem Pap. 2024; 78(1): 409-433.
35. Bangar N, Gvalani A, Ahmad S, Khan M, Tupe R. Understanding the role of glycation in the pathology of various non-communicable diseases along with novel therapeutic strategies. Glycobiology. 2022; 32(12): 1068-1088.
36. Khan I, Ullah Z, Shad AA, Fahim M, Öztürk M. In vitro antioxidant, anticholinesterase inhibitory, and antimicrobial activity studies of Terminalia chebula (Retz) and Terminalia arjuna (Roxb). S Afr J Bot. 2022; 146: 395-400.
37. Smith GL, Reutovich AA, Srivastava AK, Reichard RE, Welsh CH, Melman A, Bou-Abdallah F. Complexation of ferrous ions by ferrozine, 2,2-bipyridine and 1,10-phenanthroline: Implication for the quantification of iron in biological systems. J Inorg Biochem. 2021; 220: 111460.
38. Huang Q, Chai W-M, Ma Z-Y, Ou-Yang C, Wei Q-M, Song S, Zou ZR, Peng YY. Inhibition of α-glucosidase activity and non-enzymatic glycation by tannic acid: Inhibitory activity and molecular mechanism. Int J Biol Macromol. 2019; 141: 358-368.
39. Gao H, Huang YN, Gao B, Kawabata J. Chebulagic acid is a potent alpha-glucosidase inhibitor. Biosci Biotechnol Biochem. 2008; 72(2): 601-603.
40. Aleixandre A, Gil JV, Sineiro J, Rosell CM. Understanding phenolic acids inhibition of α-amylase and α-glucosidase and influence of reaction conditions. Food Chem. 2022; 372: 131231.
Published
Issue
Section
License
Copyright (c) 2025 Tropical Journal of Natural Product Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
